resTORbio, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
resTORbio, Inc. - overview
Established
2016
Location
Boston, MA, US
Primary Industry
Biotechnology
About
resTORbio, Inc. is a biotechnology company focused on developing therapeutics that target the aging process, aiming to enhance overall health and longevity in older adults. Founded in 2016 and headquartered in Boston, US, resTORbio, Inc. specializes in therapeutics aimed at aging-related conditions.
The company raised USD 85 mn in its IPO on January 25, 2018, and has completed three deals to date. In September 2020, it merged with Adicet Bio, Inc. , which now operates under the Adicet Bio name. resTORbio, Inc.
focuses on developing therapeutics targeting the biological mechanisms of aging, particularly aimed at enhancing health in older adults. Their pipeline includes innovative products aimed at improving healthspan and addressing age-related diseases, although specific product offerings were not detailed in the provided data. In 2019, resTORbio, Inc. reported an EBITDA of USD -85.
33 mn, reflecting its investment in research and development within the biotechnology sector. Following its recent IPO where it raised USD 85 mn, resTORbio, Inc. plans to invest in further research and development of its aging-related therapies. The company is also looking to expand its market presence, particularly targeting North America and Europe, to capitalize on the growing demand for age-related health solutions.
The merger with Adicet Bio, Inc. will support this expansion into new therapeutic areas and enhance its operational capabilities.
Current Investors
PureTech Health plc
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Epidemiology, Pharmaceutical Research & Development
Website
www.restorbio.com
Company Stage
Series B/Round 2
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.